Log In
Print
BCIQ
Print
Print this Print this
 

alosetron hydrochloride (Lotronex)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSerotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat irritable bowel syndrome (IBS); Treat women with severe, diarrhea-predominant irritable bowel syndrome (IBS-D)
Regulatory Designation

Partner

Nestle S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today